EPOS 2020: endotype-based severity and treatment of CRSwNP

Bachert C, et al.

Rhinology · 2020

Grade Bexpert opinionUnverified

Key Findings

  • Defined type 2 endotype classification
  • IL-4/IL-13/IL-5 central to CRSwNP pathogenesis
  • Epithelial barrier dysfunction as initiating event

Referenced in (1 disease)

Validation history

Full log →

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.

ID: doi-10-4193-rhin20-600DOI: 10.4193/Rhin20.600